div class=ts-pagebuttonPage 1button div class=ts-image amp-img class=ts-thumb alt=Page 1: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 2button div class=ts-image amp-img class=ts-thumb alt=Page 2: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 3button div class=ts-image amp-img class=ts-thumb alt=Page 3: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 4button div class=ts-image amp-img class=ts-thumb alt=Page 4: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 5button div class=ts-image amp-img class=ts-thumb alt=Page 5: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails5jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 6button div class=ts-image amp-img class=ts-thumb alt=Page 6: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails6jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 7button div class=ts-image amp-img class=ts-thumb alt=Page 7: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails7jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 8button div class=ts-image amp-img class=ts-thumb alt=Page 8: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails8jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 9button div class=ts-image amp-img class=ts-thumb alt=Page 9: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails9jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 10button div class=ts-image amp-img class=ts-thumb alt=Page 10: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails10jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 11button div class=ts-image amp-img class=ts-thumb alt=Page 11: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails11jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 12button div class=ts-image amp-img class=ts-thumb alt=Page 12: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails12jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 13button div class=ts-image amp-img class=ts-thumb alt=Page 13: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails13jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 14button div class=ts-image amp-img class=ts-thumb alt=Page 14: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails14jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 15button div class=ts-image amp-img class=ts-thumb alt=Page 15: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails15jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 16button div class=ts-image amp-img class=ts-thumb alt=Page 16: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails16jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 17button div class=ts-image amp-img class=ts-thumb alt=Page 17: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails17jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 18button div class=ts-image amp-img class=ts-thumb alt=Page 18: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails18jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 19button div class=ts-image amp-img class=ts-thumb alt=Page 19: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails19jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 20button div class=ts-image amp-img class=ts-thumb alt=Page 20: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails20jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 21button div class=ts-image amp-img class=ts-thumb alt=Page 21: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails21jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 22button div class=ts-image amp-img class=ts-thumb alt=Page 22: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails22jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 23button div class=ts-image amp-img class=ts-thumb alt=Page 23: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails23jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 24button div class=ts-image amp-img class=ts-thumb alt=Page 24: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails24jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 25button div class=ts-image amp-img class=ts-thumb alt=Page 25: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails25jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 26button div class=ts-image amp-img class=ts-thumb alt=Page 26: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails26jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 27button div class=ts-image amp-img class=ts-thumb alt=Page 27: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails27jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 28button div class=ts-image amp-img class=ts-thumb alt=Page 28: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails28jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 29button div class=ts-image amp-img class=ts-thumb alt=Page 29: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails29jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 30button div class=ts-image amp-img class=ts-thumb alt=Page 30: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails30jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 31button div class=ts-image amp-img class=ts-thumb alt=Page 31: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails31jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 32button div class=ts-image amp-img class=ts-thumb alt=Page 32: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails32jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 33button div class=ts-image amp-img class=ts-thumb alt=Page 33: Pusat Informasi Obat Nasional PIO Nas PIO Naspionaspomgoidsitesdefaultfilesobat_baruTecentriq Larutan · Draft Tecentriq_PI new drug application CDS 110 EN v2 Adverse src=https:reader036vdocumentspubreader036viewer20220710105fc85438eb5268311252bad6html5thumbnails33jpg width=142 height=106 layout=responsive amp-img divdiv